Quoted Securities:

58,849,054 fully paid ordinary shares

ASX Code:

NTI

Time:

1:00pm AEDT (10am WST)

Date:

4 November 2016

ASX Trade Abbreviation:

NEUROTECH

ISIN:

AU000000NTI9

Home Branch:

Perth

Industry Classification:

Technology

Registered Office:     

Level 14, 191 St Georges Terrace, Perth, Western Australia 6000

Company Secretary:                   

Fleur Louise Hudson

Share Registry:                                

Security Transfers Registrars Pty Ltd

770 Canning Highway

APPLECROSS WA 6153

Boardroom Pty Limited 

Balance Date:

30 June

CHESS:                                       

Participating. The Company will also operate an issuer sponsored sub-register

Place of Incorporation:

Australia

Dividend Policy:

See page 35 of the Company’s prospectus dated 12 September 2016

Activities:

Develops and manufactures neurotechnology devices to assist with neurological conditions.

ASX Restricted Securities:

28,487,058 fully paid ordinary shares to be classified as restricted securities for a period of 24 months from the date of admission of the Company’s securities.

699,000 fully paid ordinary shares to be classified as restricted securities for a period of 12 months from the date of issue being 9 May 2016.

10,894,390 unquoted options exercisable at $0.20 on or before 30 November 2020 to be classified as restricted securities for a period of 24 months from the date of admission of the Company’s securities.